Guangzhou Kingmed Diagnostics Group Co Ltd

603882

Company Profile

  • Business description

    Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.

  • Contact

    International Biological Island spiral three on the 10th
    Guangdong Province
    Guangzhou510000
    CHN

    T: +86 2022283222

    http://www.kingmed.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    10,413

Stocks News & Analysis

stocks

ChatGPT enters the retail space and one company surges

Investors cheer the ability to purchase directly from ChatGPT.
stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,135.9019.50-0.21%
CAC 407,850.7930.08-0.38%
DAX 4023,725.8719.19-0.08%
Dow JONES (US)46,316.0768.780.15%
FTSE 1009,273.7726.07-0.28%
HKSE26,855.56232.680.87%
NASDAQ22,591.15107.090.48%
Nikkei 22544,932.63111.12-0.25%
NZX 50 Index13,292.36159.801.22%
S&P 5006,661.2117.510.26%
S&P/ASX 2008,848.8020.50-0.23%
SSE Composite Index3,882.7820.250.52%

Market Movers